Subsequently, ZEB1-AS1 dysregulation was confirmed in varieties of digestive system cancers, including hepatocellular carcinoma, gastric cancer, and colorectal cancer [9, 13, 14]. Here, ZEB1 is linked to hepatocellular carcinoma.